CTIS2023-509905-62-00招募中1 期
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing - 49RC21_0376
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 1,424
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Age = 18 years, Consultation in one of the Emergency Departments of the participating centres, Lower limb injury requiring rigid or semi-rigid orthopaedic immobilisation, Intended duration of orthopaedic immobilisation of 2 weeks or more, Intended duration of hospitalization of 72 hours or less, TRiP(cast) score = 7, Full insurance cover, Signed and dated free informed consent
排除标准
- •Active bleeding or high risk of bleeding, Contra-indication to Rivaroxaban or LMWH, Any anticoagulant or antiplatelet treatment prior to trauma (only antiaggregant treatment authorized: aspirin < 325mg/day), Pregnant or breastfeeding woman, Factors rendering 3-month follow-up impossible, Participation in any interventional study which modifies patient care or could influence study evaluation criteria
研究者
相似试验
招募中
不适用
Rivaroxaban versus low-molecular weight heparin prior to scheduled Ultrasound evaluatioN in patients with suspected Deep Vein ThrombosisNL-OMON24892Zuyderland MC1,000
进行中（未招募）
1 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from reccuring in the leg or lungong-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolismMedDRA version: 19.0Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 19.0Level: HLTClassification code 10037439Term: Pulmonary thrombotic and embolic conditionsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 19.0Level: HLTClassification code 10034572Term: Peripheral embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 19.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-000619-26-DKBayer AG3,300
进行中（未招募）
1 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from reccuring in the leg or lungong-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolismMedDRA version: 16.1Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 16.1Level: HLTClassification code 10037439Term: Pulmonary thrombotic and embolic conditionsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 16.1Level: HLTClassification code 10034572Term: Peripheral embolism and thrombosisSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 16.1Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-000619-26-ITBayer HealthCare AG2,850
已完成
3 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus ASA in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism The Einstein Choice StudySymptomatic venous tromboembolism / Blood clots10014523NL-OMON41605Bayer200
进行中（未招募）
1 期
Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from reccuring in the leg or lungong-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and/or pulmonary embolismMedDRA version: 17.0 Level: PT Classification code 10051055 Term: Deep vein thrombosis System Organ Class: 10047065 - Vascular disordersMedDRA version: 17.0 Level: HLT Classification code 10037439 Term: Pulmonary thrombotic and embolic conditions System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 17.0 Level: PT Classification code 10037377 Term: Pulmonary embolism System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 17.0 Level: HLT Classification code 10034572 Term: Peripheral embolism and thrombosis System Organ Class: 10047065 - Vascular disordersEUCTR2013-000619-26-NOBayer HealthCare AG3,365